Novo CEO pressed by Senate to chop charges of being overweight, diabetes medicines CEO Lars Fruergaard Jørgensen informed lawmakers the corporate would consider new talks with insurers regarding the record costs of Wegovy and copyright when they pledge to maintain the medicines on their formularies. Before this summertime, the company https://milogfazx.vidublog.com/29937644/facts-about-healthcare-news-revealed